Since 1997, Propecia has been prescribed to treat male patterned baldness. Young men who took the medication reported persistent erectile dysfunction that continued following cessation of the medicine. Merck & Co., the manufacturer of Propecia, contended that any sexual side effects associated with Propecia were temporary and would go away after the medicine was stopped. Despite an increase of adverse reports of sexual problems by men using Propecia, Merck & Co. maintained this position until 2011. In March 2011, the Journal of Sexual Medicine published a study authored by Dr. Michael Irwig of George Washington University. Dr. Irwig’s study found that 205 of the men in the study suffered from sexual problems for as long as 5 years after the medication ceased.

Merck & Co. changed the warning label of Propecia in June 2011 to reflect the risk of persistent sexual dysfunction. In April 2012, the FDA publicly announced that changes would be made to the warning label accompanying Propecia. The warning label for Propecia would now include the risk of persistent erectile dysfunction, reduced libido, and orgasm and ejaculation disorders. These warning revisions brought the labeling information closer to the warnings accompanying Propecia in European countries.

The FDA mandated warning label changes came too late for many injured men who have already suffered sexual problems. Many men suffer anxiety, depression, and emotional distress because of their persistent sexual problems. Shame, anxiety, and a low self-image are common. Men who have experienced erectile dysfunction, a diminished sex drive, decreased semen production, and other issues should consider filing a Propecia lawsuit to seek compensation.  Oracle Law Group is actively investigating Propecia and offers a free consultation to men evaluating a potential claim. Call today!